Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 6, 2026 · Filed Nov 6, 2026
CVS Health's and Group President paid $2M out of pocket for CVS Health shares. It was the first purchase in over a year. Shares held went up 37% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$2,001,315
Shares × reported transaction price
$1M+
+36.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 26 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 19% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($10.4M)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-03. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
2 days after results of Nov 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $83.85 on Nov 6, 2026, 20% above its 52-week low and 24% below its high, after a 6% drop over the previous 30 trading days
52-week range $70.08 (Mar 27, 2026) to $110.60 (Jul 21, 2026), 34% of the way up, from 251 adjusted closes. 30 trading days earlier: $89.13 on Sep 25, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any CVS insider since Jun 2025. Prem S Shah's first open-market purchase of CVS in filings since 2006
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
A securities lawsuit naming the company as a defendant was filed on Mar 11, 2025 in the Court of Appeals for the First Circuit. A filing is an allegation, not a finding.
2 such cases were open. In Re: CVS Health Corp. Securities Act Litigation, docket 25-1230, via CourtListener (court records). Nature of suit 850, company named as first defendant
Federal contracts
Best 3 task order; health care data sources for surveillance of biologics. Eo 14398
The Department of Health and Human Services has committed $6.99M to CVS Health so far. It runs until Sep 29, 2027.
Federal contracts
Pharmacy medication repackaging and dispensing services
The Department of Veterans Affairs has committed $204K to CVS Health so far. It runs until Apr 1, 2027.
Fund moves
77 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
